Guidance for Albany Molecular Research Inc. (AMRI)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2017 | $1.08 – $1.20 | $1.30 | $710.00M – 740.00M | $763.30M |  Lowered |
Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | $1.00 – $1.10 | $1.10 | N/A | N/A | = Maintained | Details |
| 2016 | $1.03 – $1.11 | $1.05 | $590.00M – 615.00M | $522.50M | = Maintained | Details |
| 2015 | $0.80 – $0.90 | $0.90 | N/A | N/A | = Maintained | Details |
| 2014 | $0.87 – $0.92 | $0.92 | N/A | N/A |  Raised |
Details |
| 2013 | $0.34 – $0.52 | $0.24 | N/A | N/A | = Maintained | Details |
| 2013 | $0.60 – $0.67 | $0.64 | $210.00M – 213.00M | $251.70M | = Maintained | Details |
| Q4 2013 | $0.12 – $0.19 | $0.18 | $60.00M – 62.50M | $70.90M | = Maintained | Details |
| 2012 | N/A | N/A | $176.00M – 186.00M | N/A | = Maintained | Details |
| 2012 | $0.16 – $0.20 | $0.12 | $50.00M – 56.00M | N/A | = Maintained | Details |
| Q1 2012 | N/A | N/A | $37.00M – 40.00M | N/A | = Maintained | Details |
| 2011 | N/A | N/A | $179.00M – 187.00M | $216.50M | = Maintained | Details |
| 2011 | N/A | N/A | $43.00M – 46.00M | $50.57M | = Maintained | Details |
| 2011 | N/A | N/A | $171.00M – 175.00M | N/A | = Maintained | Details |
| 2011 | N/A | N/A | $179.00M – 187.00M | $211.25M | = Maintained | Details |
| Q4 2011 | N/A | N/A | $41.00M – 45.00M | N/A | = Maintained | Details |
| Q1 2011 | N/A | N/A | $37.00M – 41.00M | $57.38M | = Maintained | Details |
